subject: UMLS:C3827143

object_name: penis carcinoma


subject: UMLS:C3827143

subject_name: Cetuximab-IRDye 800CW

object_name: penile cancer

tested_intervention: yes


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Abdominal pain


subject: CHEBI:41879

object_name: Abdominal Pain, CTCAE


subject: GTOPDB:13769

subject_name: retatrutide

object_name: Chronic low back pain

tested_intervention: unsure


subject: CHEMBL.COMPOUND:CHEMBL5095485

subject_name: RETATRUTIDE


subject: UMLS:C5391453


subject: UNII:2Y3T5IF01Z

subject_name: Retifanlimab

object_name: Metastatic Merkel cell carcinoma


subject: UMLS:C4688466

subject_name: INCMGA 0012


subject: CHEBI:229526

subject_name: Sparsentan

object_name: Nephrotic range proteinuria


subject: PUBCHEM.COMPOUND:6427057

subject_name: ivermectin

object_name: Eosinophilic disorder


subject: PUBCHEM.COMPOUND:6427057

object_name: Eosinophilia


subject: PUBCHEM.COMPOUND:6427057

object_name: Eosinophilia, CTCAE


subject: CHEBI:6078

subject_name: Ivermectin


subject: CHEBI:6078


subject: CHEBI:6078


subject: CHEBI:16664

subject_name: Albendazole


subject: CHEBI:16664


subject: CHEBI:16664


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: Tumor Mass


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: UMLS:C4725760

subject_name: Personalized Synthetic Long Peptide Vaccine

object_name: Childhood Solid Neoplasm


subject: UMLS:C4725760

object_name: Adult Solid Neoplasm


subject: UMLS:C4725760

object_name: Solid Neoplasm


subject: PUBCHEM.COMPOUND:3367

object_name: dyskeratosis congenita, X-linked


subject: PUBCHEM.COMPOUND:3367

object_name: Revesz Syndrome


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: CHEBI:168396


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:8764


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: CHEBI:61057


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:61049


subject: UNII:3A189DH42V

subject_name: Alemtuzumab


subject: UNII:3A189DH42V


subject: UNII:NQX9KB6PCL

subject_name: Somatotropin

object_name: persian gulf syndrome


subject: UMLS:C0384570

subject_name: Recombinant Human Growth Hormone

object_name: Adult growth hormone deficiency


subject: UMLS:C0384570


subject: UMLS:C0169964

subject_name: somatropin


subject: UMLS:C2825029

subject_name: Recombinant Human Growth Hormone [EPC]


subject: UMLS:C2825029


subject: CHEBI:61057

object_name: Diabetes


subject: CHEBI:61057

object_name: diabetes mellitus


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049


subject: CHEBI:61049


subject: UMLS:C1881108

subject_name: Cell Cycle Checkpoint/DNA Repair Antagonist IC83

object_name: cancer


subject: UMLS:C1881108

object_name: neoplasm


subject: MESH:C000706843

object_name: Ischemic stroke


subject: MESH:C000706843

object_name: Acute Stroke


subject: MESH:C000706843

object_name: stroke disorder


subject: MESH:C000706843

object_name: cerebrovascular disorder


subject: MESH:C000706843

object_name: Stroke (heart beat)


subject: MESH:C000706843

object_name: Stroke, CTCAE


subject: PUBCHEM.COMPOUND:135565596

subject_name: Copanlisib

object_name: ovarian neoplasm


subject: CHEBI:173077


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: Estrogen receptor positive tumor


subject: UNII:28X28X9OKV

object_name: Menopause present (finding)


subject: UNII:28X28X9OKV

object_name: Menopause


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: CHEBI:5523

subject_name: Goserelin

object_name: Advanced prostate cancer


subject: UMLS:C0149473

subject_name: Zoladex


subject: CHEBI:144094

subject_name: bicalutamide


subject: UMLS:C0304475

subject_name: Potassium supplement


subject: UMLS:C0304475


subject: UMLS:C0304475


subject: UMLS:C0304475


subject: UMLS:C0304475

object_name: hyperglycemia


subject: UMLS:C0304475

object_name: Hyperglycemia, CTCAE


subject: UMLS:C0304475

object_name: Glucose in blood specimen above reference range


subject: CHEBI:29103


subject: CHEBI:29103


subject: CHEBI:29103


subject: CHEBI:29103


subject: CHEBI:29103


subject: CHEBI:29103


subject: CHEBI:29103


subject: CHEBI:26216

subject_name: potassium atom


subject: CHEBI:26216


subject: CHEBI:26216


subject: CHEBI:26216


subject: CHEBI:26216


subject: CHEBI:26216


subject: CHEBI:26216


subject: UMLS:C3714637

subject_name: Potassium Drug Class


subject: UMLS:C3714637


subject: UMLS:C3714637


subject: UMLS:C3714637


subject: UMLS:C3714637


subject: UMLS:C3714637


subject: UMLS:C3714637


subject: CHEBI:176381

subject_name: Diosmin

object_name: ulcerative colitis


subject: CHEBI:176381

object_name: inflammatory bowel disease 1


subject: CHEBI:82814

subject_name: Dilacor XR

object_name: coronary microvascular disorder


subject: CHEBI:82814

object_name: coronary vasospasm


subject: CHEBI:82814

object_name: Coronary microvascular dysfunction


subject: CHEBI:101278

subject_name: Diltiazem


subject: CHEBI:101278


subject: CHEBI:101278


subject: CHEBI:231679

subject_name: ipilimumab

object_name: biliary tract neoplasm


subject: UNII:CWG62Q1VTB

subject_name: Sitravatinib

object_name: Metastatic Lung Non-Squamous Non-Small Cell Carcinoma


subject: CHEBI:3127

subject_name: Bisoprolol


subject: CHEBI:3127


subject: CHEBI:3127

object_name: Variant Angina


subject: CHEBI:3127


subject: CHEBI:169833

subject_name: Deacetyldiltiazem

object_name: coronary artery disorder


subject: CHEBI:169833

object_name: coronary atherosclerosis


subject: CHEBI:169833


subject: CHEBI:169833


subject: CHEBI:169833


subject: CHEBI:169833


subject: CHEBI:82814


subject: CHEBI:82814


subject: CHEBI:82814


subject: CHEBI:101278


subject: CHEBI:101278


subject: CHEBI:101278


subject: UNII:3X8387Q25N

object_name: psoriatic arthritis


subject: CHEBI:60799

subject_name: Esketamine

object_name: respiratory failure


subject: CHEBI:60799

object_name: acute respiratory failure


subject: CHEBI:71200

subject_name: Tofacitinib

object_name: primary cutaneous amyloidosis


subject: CHEBI:50172

subject_name: acitretin


subject: PUBCHEM.COMPOUND:9824461

subject_name: remimazolam

object_name: age


subject: CHEBI:7521

subject_name: nereistoxin

object_name: alcohol abuse


subject: CHEBI:7521

object_name: alcohol dependence


subject: UMLS:C0285526

subject_name: N-telopeptide


subject: UMLS:C0285526


subject: UNII:7UWT6B0L2U

subject_name: ETOKIMAB

object_name: atopic eczema


subject: UMLS:C5238218

subject_name: Etokimab


subject: CHEBI:40279

subject_name: Allopurinol

object_name: Heart Failure, CTCAE


subject: CHEBI:3761

subject_name: Clorazepic acid

object_name: migraine


subject: CHEBI:3761

object_name: migraine with or without aura, susceptibility to, 1


subject: CHEBI:3761

object_name: migraine with aura


subject: CHEBI:3761

object_name: Common Migraine


subject: CHEBI:3761

object_name: Headache


subject: CHEBI:3761

object_name: Headache, CTCAE


subject: MESH:C031208

subject_name: specific substance maruyama

object_name: Acute Pain


subject: MESH:C031208

object_name: Low Back Pain, Mechanical


subject: RXCUI:1998624

subject_name: American house dust mite allergenic extract 6 SQ-HDM / European house dust mite allergenic extract 6 SQ-HDM Sublingual Tablet

object_name: Allergic asthma caused by Dermatophagoides pteronyssinus


subject: CHEBI:17203

subject_name: Proline

object_name: Intensive care unit acquired weakness


subject: UMLS:C3641863

object_name: urothelial carcinoma


subject: UMLS:C3641863

object_name: transitional cell carcinoma


subject: UMLS:C3641863

object_name: nonpapillary renal cell carcinoma


subject: UMLS:C3641863

object_name: clear cell renal carcinoma


subject: UMLS:C3641863

object_name: renal cell adenocarcinoma


subject: UMLS:C3641863

object_name: renal cell carcinoma


subject: CHEBI:43602

subject_name: Obeticholic acid

object_name: familial partial lipodystrophy


subject: CHEBI:134703

subject_name: Fluciclovine (18F)

object_name: Stage IV Prostate Cancer AJCC v6


subject: CHEBI:134703

object_name: Carcinoma of the prostate stage IV


subject: CHEBI:134703

object_name: Stage IV Prostate Cancer AJCC v7


subject: CHEBI:134703

object_name: Stage IV Prostate Cancer AJCC v8


subject: CHEBI:134703

object_name: Prostate Carcinoma Metastatic in the Bone


subject: UMLS:C2699489

subject_name: sonepcizumab

object_name: Solid Neoplasm


subject: CHEMBL.COMPOUND:CHEMBL2109570

subject_name: SONEPCIZUMAB


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: beta thalassemia


subject: CHEBI:2038

subject_name: Azacitidine


subject: CHEBI:404903

subject_name: Ertapenem

object_name: Allergy


subject: CHEBI:404903

object_name: History of allergies


subject: CHEBI:404903

object_name: IgE responsiveness, atopic


subject: UMLS:C5669600

subject_name: Ivonescimab

object_name: Metastatic Pancreatic Ductal Adenocarcinoma


subject: GTOPDB:12966

subject_name: cadonilimab


subject: CHEMBL.COMPOUND:CHEMBL4594456

subject_name: CADONILIMAB


subject: UMLS:C4727210

subject_name: Cadonilimab


subject: CHEBI:66903

subject_name: Vismodegib

object_name: Keratocystic odontogenic tumor


subject: CHEMBL.COMPOUND:CHEMBL2109341

object_name: HIV infection


subject: GTOPDB:4934

subject_name: G-CSF

object_name: stiff-person syndrome


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: CHEBI:31824

subject_name: Mesna


subject: CHEBI:17905

subject_name: Coenzyme M


subject: CHEBI:6888

subject_name: Methylprednisolone


subject: UMLS:C0359156

subject_name: Thymoglobulin


subject: CHEBI:25812

subject_name: Ozone

object_name: Neck pain


subject: UMLS:C5854473

subject_name: Anti-EpCAM/Anti-CD3 Bispecific Antibody BA3182

object_name: Advanced Adenocarcinoma


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: familial pterygium of the conjunctiva


subject: PUBCHEM.COMPOUND:14907381

object_name: pterygium


subject: PUBCHEM.COMPOUND:14907381

object_name: conjunctival pterygium


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus


subject: CHEBI:190410


subject: CHEBI:190410


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: CHEBI:46345


subject: UMLS:C0617623

subject_name: Lidocaine / Prilocaine

object_name: Uses contraception (finding)


subject: CHEBI:71954

subject_name: Buparlisib

object_name: leukemia


subject: CHEBI:71954

object_name: childhood leukemia


subject: CHEBI:6888

object_name: traumatic brain injury


subject: CHEBI:73612

subject_name: Met-Pro

object_name: traumatic encephalopathy


subject: CHEBI:73612


subject: UNII:BE9PTC7J7P

subject_name: MP


subject: UNII:BE9PTC7J7P


subject: CHEBI:2208

subject_name: Mercaptopurine


subject: CHEBI:2208


subject: UNII:7D0YB67S97

subject_name: Abatacept

object_name: Crohn disease


subject: UMLS:C0378942


subject: CHEBI:140592

subject_name: Onalespib

object_name: Stage IVB Laryngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:140592

object_name: Stage IVA Laryngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:140592

object_name: Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:140592

object_name: Oropharyngeal squamous cell carcinoma stage III


subject: CHEBI:140592

object_name: Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:140592

object_name: Stage IVB Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:140592

object_name: Stage IVB Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:140592

object_name: Stage IVA Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:140592

object_name: Squamous cell carcinoma of the oral cavity stage III


subject: CHEBI:140592

object_name: Stage IVB Hypopharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:140592

object_name: Stage IVA Hypopharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:140592

object_name: Hypopharyngeal squamous cell carcinoma stage III


subject: HMDB:HMDB0259842

subject_name: Visudyne

object_name: macular degeneration


subject: HMDB:HMDB0259842

object_name: retinitis pigmentosa 30


subject: HMDB:HMDB0259842

object_name: choroidal neovascularization


subject: HMDB:HMDB0259842

object_name: choroidal neovascularization (physical finding)


subject: PUBCHEM.COMPOUND:53477739

subject_name: Vasopressin

object_name: Circulatory perfusion disorder


subject: PUBCHEM.COMPOUND:53477739

object_name: congenital heart disease


subject: PUBCHEM.COMPOUND:11979316


subject: PUBCHEM.COMPOUND:11979316


subject: UMLS:C5966161

subject_name: Vasopressin (anatomical)


subject: UMLS:C5966161


subject: CHEBI:32696


subject: CHEBI:32696

object_name: Single Ventricle Defect


subject: CHEBI:32696

object_name: Single ventricle


subject: CHEBI:32696


subject: CHEBI:16467

subject_name: Arginine


subject: CHEBI:16467


subject: CHEBI:16467


subject: CHEBI:16467


subject: CHEBI:8884

subject_name: Rocuronium

object_name: Hypoxemia


subject: CHEBI:8884

object_name: Blood oxygen concentration below reference range (finding)


subject: CHEMBL.COMPOUND:CHEMBL4297683

object_name: biliary tract cancer


subject: CHEMBL.COMPOUND:CHEMBL4297683

object_name: pancreatic neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4297683

object_name: exocrine pancreatic carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297683

object_name: malignant pancreatic neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4297683

object_name: Stomach cancer


subject: CHEMBL.COMPOUND:CHEMBL4297683

object_name: gastric cancer


subject: CHEMBL.COMPOUND:CHEMBL4297683

object_name: colorectal cancer


subject: CHEMBL.COMPOUND:CHEMBL4297683

object_name: colorectal carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297683

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C4524907

subject_name: Anti-AG7 Antibody Drug Conjugate AbGn-107


subject: UMLS:C4524907


subject: UMLS:C4524907


subject: UMLS:C4524907


subject: UMLS:C4524907


subject: UMLS:C4524907


subject: UMLS:C4524907


subject: UMLS:C4524907


subject: UMLS:C4524907


subject: CHEBI:48923

subject_name: erythromycin

object_name: Apnea


subject: CHEBI:48923

object_name: Apnea, CTCAE


subject: CHEBI:48923

object_name: Bradycardia by ECG Finding


subject: CHEBI:48923

object_name: Bradycardia


subject: CHEBI:48923

object_name: Heartburn


subject: CHEBI:42355

subject_name: Erythromycin


subject: CHEBI:42355


subject: CHEBI:42355


subject: CHEBI:42355


subject: CHEBI:42355


subject: CHEBI:64312

subject_name: Memantine

object_name: learning disability


subject: CHEBI:32816

subject_name: Pyruvic acid


subject: PUBCHEM.COMPOUND:156963740

subject_name: Dasiglucagon

object_name: Reactive hypoglycemia


subject: PUBCHEM.COMPOUND:156963740

object_name: hyperinsulinemic hypoglycemia


subject: UMLS:C0694951

subject_name: INJECTION, AMPHOTERICIN B, 50 MG ADMINISTERED

object_name: chronic mucocutaneous candidiasis


subject: CHEBI:2682

subject_name: Amphotericin B


subject: CHEBI:2788

subject_name: Apraclonidine

object_name: myasthenia gravis


subject: CHEBI:2788

object_name: Myasthenia Gravis, CTCAE


subject: CHEBI:2788

object_name: Myasthenia Gravis, Ocular


subject: MESH:C574044

subject_name: Proxelan

object_name: chronic prostatitis


subject: MESH:C574044

object_name: Prostatitis category III (National Institute of Health classification)


subject: MESH:C574044

object_name: premature ejaculation


subject: CHEBI:38290

subject_name: L-ascorbate

object_name: Postoperative depression


subject: CHEBI:176783

subject_name: vitamin C


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: PUBCHEM.COMPOUND:92043599

subject_name: epoetin alfa

object_name: vitamin C measurement


subject: PUBCHEM.COMPOUND:92043599


subject: CHEBI:81579

subject_name: Erythropoietin


subject: CHEBI:81579


subject: CHEBI:36005

subject_name: docosahexaenoic acid


subject: CHEBI:36005


subject: CHEBI:16016

subject_name: Glycerone


subject: CHEBI:16016


subject: CHEBI:28689

subject_name: Prasterone


subject: CHEBI:28689


subject: CHEBI:28125

subject_name: Doconexent


subject: CHEBI:28125


subject: HMDB:HMDB0303246

subject_name: Lignin


subject: HMDB:HMDB0303246

object_name: cardiovascular disorder


subject: HMDB:HMDB0303246


subject: PUBCHEM.COMPOUND:66964417

subject_name: LACTULOSE


subject: PUBCHEM.COMPOUND:66964417


subject: PUBCHEM.COMPOUND:66964417


subject: UNII:9U7D5QH5AE


subject: UNII:9U7D5QH5AE


subject: UNII:9U7D5QH5AE


subject: UMLS:C0020616

subject_name: Hypoglycemic Agents

object_name: type 2 diabetes mellitus


subject: CHEBI:6887

subject_name: Methylphenidate

object_name: digestive system cancer


subject: CHEBI:6887

object_name: Childhood Breast Carcinoma


subject: CHEBI:6887

object_name: breast carcinoma


subject: CHEBI:6887

object_name: breast cancer


subject: PUBCHEM.COMPOUND:168012576

subject_name: Sinoporphyrin sodium

object_name: esophageal squamous cell carcinoma


subject: MESH:C586896

subject_name: sinoporphyrin sodium


subject: CHEBI:9316

subject_name: Sufentanil

object_name: Myocardial injury


subject: CHEBI:92157

subject_name: octadeca-9,12-dienoic acid

object_name: multiple sclerosis


subject: CHEBI:75108

subject_name: linoelaidic acid


subject: CHEBI:36021

subject_name: octadec-9-enoic acid


subject: CHEBI:16196

subject_name: oleic acid


subject: PUBCHEM.COMPOUND:131648253

subject_name: PEN

object_name: inflammatory bowel disease 1


subject: UNII:66Q80IL7CW

subject_name: Penclomedine


subject: CHEBI:63608

subject_name: Maraviroc

object_name: Post stroke depression


subject: CHEBI:2549

subject_name: Albuterol

object_name: hypersensitivity pneumonitis


subject: CHEBI:2549

object_name: Small airways disease


subject: UMLS:C1527137

subject_name: Recombinant melatonin

object_name: ulcerative colitis


subject: UMLS:C1527137


subject: CHEBI:16796

subject_name: Melatonin


subject: CHEBI:16796


subject: CHEBI:229274

subject_name: Nicotinamide riboside chloride

object_name: hyperlipidemia


subject: CHEBI:229274

object_name: Lipidemias


subject: UMLS:C4476285

subject_name: Nicotinamide Riboside Chloride


subject: UMLS:C4476285


subject: UMLS:C4764354

subject_name: Niagen


subject: UMLS:C4764354


subject: PUBCHEM.COMPOUND:76322320

subject_name: COLISTIN

object_name: Infection of musculoskeletal system


subject: CHEBI:37943

subject_name: colistin


subject: PUBCHEM.COMPOUND:131751089

subject_name: Majoroside F6

object_name: Inflammation


subject: PUBCHEM.COMPOUND:131751089

object_name: infection as a complication


subject: PUBCHEM.COMPOUND:131751089

object_name: multiple organ dysfunction syndrome


subject: CHEBI:28300

subject_name: glutamine


subject: CHEBI:28300


subject: CHEBI:61049

subject_name: Tacrolimus

object_name: Burn injury


subject: MESH:D056692

subject_name: Prebiotics

object_name: morbid obesity


subject: CHEBI:74947

subject_name: Thalidomide

object_name: Childhood Glioblastoma


subject: CHEBI:74947

object_name: adult glioblastoma


subject: CHEBI:63633

subject_name: Triptorelin

object_name: Drug toxicity


subject: UNII:SI8K6KX6FA

object_name: Crohn disease


subject: CHEBI:15551

subject_name: Dinoprostone

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:15551

object_name: obesity


subject: CHEBI:15551

object_name: Obesity, CTCAE


subject: CHEBI:177451

subject_name: Fasiglifam

object_name: Diabetes


subject: CHEBI:94807

subject_name: Nitazoxanide

object_name: Irritable bowel syndrome with diarrhea


subject: UNII:07JNL92FG4

object_name: hypercholesterolemia, familial, 1


subject: UNII:07JNL92FG4

object_name: familial hypercholesterolemia


subject: UNII:9060PRM18Q

subject_name: CAT'S CLAW

object_name: Solid Neoplasm


subject: UMLS:C1321600

subject_name: Silver nitrate stain

object_name: dental caries


subject: UMLS:C1321600

object_name: Dental Caries, CTCAE


subject: CHEBI:32130

subject_name: Silver nitrate


subject: CHEBI:32130


subject: UMLS:C1161347

subject_name: Argentum nitricum, silver nitrate


subject: UMLS:C1161347


subject: CHEBI:27834

subject_name: Pentostatin

object_name: carcinoma of esophagus


subject: CHEBI:27834

object_name: esophageal cancer


subject: CHEBI:27834

object_name: Childhood Esophageal Carcinoma


subject: CHEBI:27834

object_name: neoplasm of esophagus


subject: CHEBI:94329

subject_name: Oxyphenonium


subject: CHEBI:94329


subject: CHEBI:94329


subject: CHEBI:94329


subject: UNII:0K5743G68X

subject_name: Lemborexant

object_name: kidney failure


subject: CHEBI:87715

subject_name: Prasugrel

object_name: Sepsis


subject: CHEBI:87715

object_name: Sepsis, CTCAE


subject: PUBCHEM.COMPOUND:5281767

subject_name: CURCUMIN

object_name: Infection by Candida albicans


subject: UNII:BIU7Q7W2SH

subject_name: Rose Bengal B


subject: CHEBI:87202

subject_name: Rose bengal


subject: CHEBI:52261

subject_name: rose bengal


subject: UMLS:C1881485

subject_name: Lutetium Lu-177 Girentuximab

object_name: Metastatic Renal Cell Carcinoma


subject: UMLS:C1881485

object_name: Metastatic Renal Cell Cancer


subject: UNII:RDF76R62ID

subject_name: LAROTRECTINIB SULFATE

object_name: Refractory Ependymoma


subject: UNII:RDF76R62ID

object_name: Refractory Soft Tissue Sarcoma


subject: UNII:RDF76R62ID

object_name: Refractory Malignant Glioma


subject: UNII:RDF76R62ID

object_name: Refractory Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor


subject: UNII:RDF76R62ID

object_name: Recurrent tumors of the Ewing's family


subject: UNII:RDF76R62ID

object_name: Recurrent Kidney Wilms Tumor


subject: UNII:RDF76R62ID

object_name: Recurrent Malignant Glioma


subject: UNII:RDF76R62ID

object_name: Recurrent Rhabdomyosarcoma


subject: UNII:PF9462I9HX

subject_name: Larotrectinib


subject: UNII:PF9462I9HX


subject: UNII:PF9462I9HX


subject: UNII:PF9462I9HX


subject: UNII:PF9462I9HX


subject: UNII:PF9462I9HX


subject: UNII:PF9462I9HX


subject: UNII:PF9462I9HX


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: seasonal affective disorder


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UNII:T34SH2H9HI

subject_name: Olorofim

object_name: invasive aspergillosis


subject: UMLS:C1720782

subject_name: Niosomes

object_name: lung disorder


subject: UMLS:C1720782

object_name: History of - respiratory disease


subject: UMLS:C1720782

object_name: Drug action (disorder)


subject: UMLS:C5237262

subject_name: LRP5/6 Antagonist BI 905677

object_name: neoplasm


subject: UMLS:C5418091

subject_name: Fidasimtamab

object_name: Stomach cancer


subject: UMLS:C5418091

object_name: gastric cancer


subject: UMLS:C5418091

object_name: Gastroesophageal junction cancer


subject: UMLS:C4744993


subject: CHEBI:45783

subject_name: Imatinib

object_name: adult acute respiratory distress syndrome


subject: CHEBI:45783

object_name: familial acute respiratory distress syndrome, ANLN-related, dog


subject: CHEBI:45783

object_name: COVID-19-Associated Acute Respiratory Distress Syndrome


subject: CHEBI:45783

object_name: pulmonary edema


subject: CHEBI:45783

object_name: Acute respiratory distress syndrome due to COVID-19


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: shoulder joint disorder


subject: CHEBI:4466

subject_name: Dexmedetomidine


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UMLS:C5203174

subject_name: Epinephrine Liquid Injection

object_name: anaphylaxis


subject: UMLS:C5203174

object_name: Anaphylaxis;non medication


subject: UMLS:C5203174

object_name: Anaphylaxis, CTCAE


subject: PUBCHEM.COMPOUND:71301236

object_name: liver failure


subject: UMLS:C3850864


subject: UNII:8202AY8I7H

subject_name: Eptinezumab

object_name: Episodic Cluster Headache


subject: UMLS:C2752138

subject_name: aloe vera homeopathic preparation

object_name: Hyperoxaluria


subject: DRUGBANK:DB13906

subject_name: Aloe vera leaf


subject: UMLS:C0995182

subject_name: Aloe vera preparation


subject: DRUGBANK:DB14235

subject_name: Bilberry


subject: CHEMBL.COMPOUND:CHEMBL2108924

subject_name: CINNAMON


subject: UMLS:C0939899

subject_name: cinnamon preparation


subject: DRUGBANK:DB10631

subject_name: Cranberry


subject: UMLS:C0453273

subject_name: cranberry preparation


subject: UMLS:C1704263

subject_name: green tea extract


subject: DRUGBANK:DB14307

subject_name: Green tea leaf


subject: UNII:U946SH95EE

subject_name: Milk thistle


subject: UMLS:C0872906

subject_name: milk thistle seed extract


subject: PUBCHEM.COMPOUND:131751561

subject_name: Cyclostenol


subject: DRUGBANK:DB14276

subject_name: Turmeric


subject: PUBCHEM.COMPOUND:5281767

subject_name: CURCUMIN


subject: UMLS:C2983748

subject_name: Lactobacillus plantarum strain 299v

object_name: diarrhea


subject: UMLS:C2983748

object_name: rectal discharge diarrhea (physical finding)


subject: UMLS:C2983748

object_name: Diarrhea, CTCAE


subject: UMLS:C2983748

object_name: unspecified adult solid tumor, protocol specific


subject: CHEBI:137245

subject_name: Asp-Pro

object_name: pregnancy related


subject: CHEBI:4653

subject_name: Dipyridamole


subject: MESH:C000727548

object_name: basal cell carcinoma


subject: MESH:C000727548

object_name: skin basal cell carcinoma


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Platinum-Resistant Urothelial Carcinoma


subject: CHEBI:44241

subject_name: Metyrapone

object_name: adrenal gland hyperfunction


subject: CHEBI:7953

subject_name: Pemoline

object_name: infertility


subject: RXCUI:1999664

subject_name: bictegravir / emtricitabine / tenofovir alafenamide Oral Product

object_name: coronary artery disorder


subject: RXCUI:1999664

object_name: coronary atherosclerosis


subject: CHEBI:9168

subject_name: Sirolimus

object_name: liver cancer


subject: CHEBI:9168

object_name: Adult Liver Carcinoma


subject: UNII:4B93MGE4AL

subject_name: Futibatinib

object_name: Advanced Cholangiocarcinoma


subject: UNII:C79C39DU7U

object_name: interstitial lung disease 1


subject: UNII:C79C39DU7U

object_name: interstitial lung disease 2


subject: UMLS:C1881373

subject_name: Synthetic Levothyroxine

object_name: myocardial infarction


subject: UMLS:C1881373

object_name: Myocardial Infarction, CTCAE


subject: UMLS:C1881373

object_name: Myocardial Infarction by ECG Finding


subject: CHEBI:18332

subject_name: Levothyroxine


subject: CHEBI:18332


subject: CHEBI:18332


subject: UNII:C9H2L21V7U

subject_name: SMOFlipid


subject: CHEMBL.COMPOUND:CHEMBL3833331

object_name: multiple sclerosis


subject: UMLS:C4687467

subject_name: Anti-IL17A Monoclonal Antibody CJM112

object_name: asthma


subject: DRUGBANK:DB18582

object_name: Duchenne muscular dystrophy


subject: CHEBI:229233

subject_name: Ritlecitinib

object_name: vitiligo-associated multiple autoimmune disease susceptibility 1


subject: CHEBI:229233

object_name: vitiligo


subject: UNII:H52ITZ9X9D

subject_name: ACASUNLIMAB

object_name: melanoma


subject: UNII:H52ITZ9X9D

object_name: skin melanoma


subject: UMLS:C5417901

subject_name: BNT 311


subject: UMLS:C5417901


subject: UNII:D959AE5USF

subject_name: clofazimine

object_name: drug-resistant tuberculosis


subject: UNII:6GNT3Y5LMF

subject_name: LEVOFLOXACIN


subject: CHEBI:63598

subject_name: Levofloxacin


subject: PUBCHEM.COMPOUND:11756905

subject_name: Delamanid


subject: CHEBI:63607

subject_name: Linezolid


subject: UMLS:C0699319

subject_name: Cytoxan


subject: UNII:5TAA004E22

subject_name: Sargramostim

object_name: Parkinson's disease and parkinsonism


subject: PR:000005931


subject: CHEBI:41139

subject_name: BETAINE

object_name: endogenous depression


subject: CHEBI:41139

object_name: major depressive disorder


subject: PUBCHEM.COMPOUND:135405876

subject_name: Folate


subject: PUBCHEM.COMPOUND:135405876


subject: CHEBI:62501


subject: CHEBI:62501


subject: CHEBI:37445

subject_name: folic acids


subject: CHEBI:37445


subject: UMLS:C0178638

subject_name: folate


subject: UMLS:C0178638


subject: CHEBI:67011

subject_name: folates


subject: CHEBI:67011


subject: CHEBI:27470

subject_name: Folic acid


subject: CHEBI:27470


subject: CHEBI:151

subject_name: ISOCITRIC ACID

object_name: Advanced Melanoma


subject: PUBCHEM.COMPOUND:49865963

subject_name: TRABECTEDIN

object_name: Childhood Solid Neoplasm


subject: PUBCHEM.COMPOUND:3199

subject_name: ecteinascidin 743


subject: CHEBI:134718

subject_name: Safinamide

object_name: Hepatic impairment


subject: UNII:4988K7X26P

subject_name: Fosamax

object_name: cerebral palsy


subject: CHEBI:2567

subject_name: Alendronic acid


subject: UMLS:C5226618

object_name: rheumatoid arthritis


subject: CHEBI:7627

subject_name: Norethisterone

object_name: Encounter due to presence of intrauterine contraceptive device


subject: PUBCHEM.COMPOUND:3267

subject_name: Estradiol valerate


subject: PUBCHEM.COMPOUND:115350

subject_name: Mesigyna


subject: UMLS:C0256136


subject: CHEBI:23965

subject_name: estradiol


subject: UMLS:C4519149

object_name: Acute Stroke


subject: CHEBI:73604

subject_name: Lys-Gly


subject: CHEBI:44915

subject_name: Propofol

object_name: anesthesia; functional


subject: CHEBI:44915

object_name: Bradycardia


subject: CHEBI:30879

subject_name: alcohol

object_name: Fanconi anemia


subject: CHEBI:30879

object_name: Fanconi anemia complementation group A


subject: CHEBI:30879

object_name: oral cavity carcinoma


subject: CHEBI:30879

object_name: Alcohol-Related Carcinoma


subject: CHEBI:16236

subject_name: Ethanol


subject: CHEBI:16236


subject: CHEBI:16236


subject: CHEBI:16236


subject: UMLS:C5783881

subject_name: Anti-CD137/Anti-FAP Bispecific Antibody BI 765179

object_name: neoplasm


subject: CHEBI:73611

subject_name: Met-Gly

object_name: hematopoietic stem cell transplantation-associated thrombotic microangiopathy


subject: CHEBI:25107

subject_name: magnesium atom


subject: PR:000004501

subject_name: attractin


subject: UMLS:C0487173

subject_name: Mg antigen


subject: UNII:38073MQB2A

subject_name: Umbralisib

object_name: Hodgkin Disease


subject: CHEBI:9398

subject_name: Tamsulosin

object_name: Stress urinary incontinence


subject: CHEBI:9398

object_name: pelvic organ prolapse


subject: UMLS:C5959329

subject_name: AXL Inhibitor AB801

object_name: cancer


subject: UMLS:C5959329


subject: UNII:B2K5L1L8S9

subject_name: Surufatinib

object_name: lung carcinoid tumor


subject: UNII:B2K5L1L8S9

object_name: small intestine neuroendocrine tumor, well differentiated, low or intermediate grade


subject: PUBCHEM.COMPOUND:42606390

object_name: premature ejaculation


subject: UNII:VN9EXL272Y


subject: UMLS:C5555917

subject_name: Pamvatamig

object_name: Childhood Solid Neoplasm


subject: UMLS:C5555917

object_name: Adult Solid Neoplasm


subject: UMLS:C5555917

object_name: Solid Neoplasm


subject: UMLS:C5555917

object_name: Neck Carcinoma


subject: UMLS:C5555917

object_name: head and neck neoplasm


subject: UMLS:C5555917

object_name: head and neck cancer


subject: UMLS:C2714710

object_name: Staphylococcal Skin Infections


subject: UMLS:C5964783

object_name: kidney failure


subject: CHEBI:27732

subject_name: Caffeine

object_name: prostate carcinoma


subject: CHEBI:27732

object_name: prostate cancer


subject: CHEBI:146178

subject_name: RACEMETHORPHAN


subject: CHEBI:146178


subject: CHEBI:146176

subject_name: levomethorphan


subject: CHEBI:146176


subject: CHEBI:4470

subject_name: Dextromethorphan


subject: CHEBI:4470


subject: UMLS:C5706362

subject_name: Mutant-selective EGFR Inhibitor BDTX-1535

object_name: glioblastoma


subject: UMLS:C5706362

object_name: Childhood Glioblastoma


subject: UMLS:C5706362

object_name: adult glioblastoma


subject: UMLS:C5706362

object_name: High grade glioma


subject: UMLS:C5706362

object_name: malignant glioma


subject: PUBCHEM.COMPOUND:5281767

subject_name: CURCUMIN

object_name: endogenous depression


subject: PUBCHEM.COMPOUND:5281767

object_name: major depressive disorder


subject: CHEBI:114785

subject_name: Erlotinib

object_name: familial adenomatous polyposis 1


subject: CHEBI:9352

subject_name: Sulindac


subject: CHEBI:8228

subject_name: Pioglitazone

object_name: hypogonadism


subject: UMLS:C0086466

subject_name: Injectables

object_name: no feeling or sensation of skin


subject: UMLS:C0086466

object_name: Sensory Loss


subject: UMLS:C4289970

subject_name: Anti-PD1 Monoclonal Antibody

object_name: head and neck squamous cell carcinoma


subject: CHEBI:32016

subject_name: Pirfenidone

object_name: Hermansky-Pudlak syndrome


subject: UMLS:C4527193

object_name: Neck Carcinoma


subject: UMLS:C4527193

object_name: head and neck neoplasm


subject: UMLS:C4527193

object_name: head and neck cancer


subject: UMLS:C4733584


subject: UMLS:C4733584


subject: UMLS:C4733584


subject: UMLS:C4528734


subject: UMLS:C4528734


subject: UMLS:C4528734


subject: UMLS:C3850285

object_name: HIV infection


subject: UMLS:C3712108


subject: UMLS:C3713322


subject: CHEBI:29947

subject_name: glycine residue

object_name: abdominal obesity-metabolic syndrome


subject: CHEBI:29947

object_name: metabolic syndrome X


subject: CHEBI:29947

object_name: Dyslipidemia


subject: CHEBI:29947

object_name: diabetes mellitus


subject: CHEBI:29947

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:29947

object_name: obesity


subject: CHEBI:29947

object_name: Obesity, CTCAE


subject: CHEBI:15428

subject_name: Glycine


subject: CHEBI:15428


subject: CHEBI:15428


subject: CHEBI:15428


subject: CHEBI:15428


subject: CHEBI:15428


subject: CHEBI:15428


subject: PUBCHEM.COMPOUND:18319735

subject_name: Mirabegron

object_name: cauda equina syndrome with neurogenic bladder


subject: PUBCHEM.COMPOUND:18319735

object_name: Cognitive changes


subject: UMLS:C0021027

subject_name: Immunoglobulins

object_name: Alzheimer disease


subject: CHEBI:3139

subject_name: bleomycin

object_name: Childhood Breast Carcinoma


subject: CHEBI:3139

object_name: breast carcinoma


subject: CHEBI:3139

object_name: breast cancer


subject: CHEBI:3139

object_name: Carcinoma breast stage IV


subject: CHEBI:3139

object_name: Breast cancer recurrent


subject: UMLS:C1541356

object_name: non-small cell lung carcinoma


subject: CHEBI:6121

subject_name: Ketamine

object_name: Wounds and Injuries


subject: CHEBI:64317

subject_name: Isoprenaline

object_name: Anorexia


subject: CHEBI:107736

subject_name: Metoclopramide

object_name: acute myocardial infarction


subject: CHEBI:107736

object_name: Acute Myocardial Infarction by ECG Finding


subject: CHEBI:74705

subject_name: Met-Leu

object_name: renal cirrhosis


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: PUBCHEM.COMPOUND:5339

subject_name: Sulfasalazine

object_name: acute myeloid leukemia by FAB classification


subject: PUBCHEM.COMPOUND:5339

object_name: acute myeloid leukemia


subject: CHEBI:17234

subject_name: D-glucose

object_name: Air leaking from lung


subject: CHEBI:4708

subject_name: Doxazosin

object_name: cocaine abuse


subject: CHEBI:4708

object_name: Harmful pattern of substance use


subject: CHEBI:4708

object_name: substance abuse


subject: CHEMBL.COMPOUND:CHEMBL2109530

object_name: rheumatoid arthritis


subject: CHEBI:7492

subject_name: Nedocromil

object_name: lung disorder


subject: UMLS:C0939219

subject_name: atovaquone / proguanil

object_name: Plasmodium falciparum infection


subject: PUBCHEM.COMPOUND:2269


subject: UMLS:C0812732

subject_name: INJECTION, AZITHROMYCIN, 500 MG ADMINISTERED


subject: CHEBI:2955

subject_name: Azithromycin


subject: PUBCHEM.COMPOUND:66964417

subject_name: LACTULOSE

object_name: colonic disease


subject: UNII:9U7D5QH5AE


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin

object_name: anus cancer


subject: PUBCHEM.COMPOUND:43805

object_name: anal carcinoma


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: CHEBI:184693

subject_name: GRANISETRON

object_name: cervical cancer


subject: CHEBI:184693

object_name: cervical carcinoma


subject: CHEBI:7773

subject_name: Ondansetron


subject: CHEBI:7773


subject: UNII:FR2W015BG1

object_name: multiple sclerosis


subject: UMLS:C2981824


subject: MESH:C000720466

subject_name: GRT-R910 vaccine


subject: CHEBI:71196

subject_name: glucagon-like peptide-1 receptor agonist

object_name: abdominal obesity-metabolic syndrome


subject: CHEBI:71196

object_name: metabolic syndrome X


subject: CHEBI:71196

object_name: Obstructive sleep apnea of adult


subject: CHEBI:71196

object_name: hypertension


subject: CHEBI:71196

object_name: Hypertension, CTCAE


subject: UMLS:C2917359

subject_name: GLP-1 Receptor Agonist [EPC]


subject: UMLS:C2917359


subject: UMLS:C2917359

object_name: morbid obesity


subject: UMLS:C2917359


subject: UMLS:C2917359


subject: UMLS:C2917359


subject: CHEBI:51254

subject_name: AMOXICILLIN

object_name: malnutrition


subject: PUBCHEM.COMPOUND:2171


subject: CHEBI:2676

subject_name: Amoxicillin


subject: UMLS:C0874041

subject_name: watermelon preparation

object_name: Postmenopausal


subject: UMLS:C0874041

object_name: Overweight and obesity


subject: DRUGBANK:DB10578

subject_name: Watermelon


subject: DRUGBANK:DB10578


subject: CHEBI:51799

subject_name: Imipenem

object_name: acute pancreatitis


subject: CHEBI:190509


subject: CHEBI:71200

subject_name: Tofacitinib

object_name: vertebral joint disorder


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Ocular histoplasmosis syndrome


subject: UNII:2S9ZZM9Q9V

object_name: angioid streaks


subject: UNII:2S9ZZM9Q9V

object_name: myopia


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: multifocal choroiditis


subject: CHEBI:41879

object_name: punctate inner choroidopathy


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:90001

subject_name: cystathionine ketimine

object_name: Pathologic Neovascularization


subject: CHEBI:28082


subject: UMLS:C3813556

subject_name: Cancer/Testis Antigen


subject: PR:000050337

subject_name: mature calcitonin


subject: MESH:C000620181

object_name: chronic hepatitis C virus infection


subject: UMLS:C3273454


subject: CHEBI:90936

subject_name: Alectinib

object_name: Hepatic impairment


subject: PUBCHEM.COMPOUND:11306691

subject_name: rac-Sitagliptin

object_name: Moderate albuminuria


subject: CHEBI:40237

subject_name: Sitagliptin


subject: MESH:D006170

subject_name: Gum Arabic

object_name: Constipation


subject: MESH:D006170

object_name: Constipation, CTCAE


subject: UMLS:C2093618

subject_name: arabic gum allergenic extract


subject: UMLS:C2093618


subject: DRUGBANK:DB10451

subject_name: Acacia


subject: DRUGBANK:DB10451


subject: UMLS:C4727210

subject_name: Cadonilimab

object_name: Non-clear cell renal cell carcinoma


subject: UMLS:C4727210

object_name: sarcomatoid renal cell carcinoma


subject: CHEBI:66910

subject_name: Axitinib


subject: UMLS:C4054250

object_name: Stage IV Lung Cancer AJCC v8


subject: UMLS:C4054250

object_name: Stage IVB Lung Cancer AJCC v8


subject: UMLS:C4054250

object_name: Stage IVA Lung Cancer AJCC v8


subject: UMLS:C4054250

object_name: lung carcinoma


subject: UMLS:C4054250

object_name: Secondary malignant neoplasm of lung


subject: PUBCHEM.COMPOUND:11972243

subject_name: Anisodine hydrobromide

object_name: Common Migraine


subject: PUBCHEM.COMPOUND:11972243

object_name: migraine with aura


subject: PUBCHEM.COMPOUND:4105431

subject_name: ANISODINE HYDROBROMIDE


subject: PUBCHEM.COMPOUND:4105431


subject: UMLS:C3252364

subject_name: anisodine hydrobromide


subject: UMLS:C3252364


subject: PUBCHEM.COMPOUND:4479094

subject_name: Doxercalciferol

object_name: vitamin D deficiency


subject: CHEBI:95341

subject_name: Baricitinib

object_name: pyoderma gangrenosum


subject: CHEBI:95341

object_name: pyoderma


subject: CHEBI:95341

object_name: Wound healed (finding)


subject: CHEBI:95341

object_name: Skin ulcer


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: follicular dendritic cell sarcoma


subject: UNII:DPT0O3T46P

object_name: dendritic cell sarcoma


subject: UNII:DPT0O3T46P

object_name: histiocytic sarcoma


subject: UNII:DPT0O3T46P

object_name: interdigitating dendritic cell sarcoma


subject: CHEBI:68579

subject_name: Rivaroxaban

object_name: ventricular mural thrombosis


subject: PUBCHEM.COMPOUND:160883

subject_name: Butylscopolamine

object_name: intestinal disorder


subject: UMLS:C4086732

subject_name: ANF-Rho

object_name: neutropenia, chronic familial


subject: CHEBI:9150

subject_name: Simvastatin

object_name: end stage renal failure


subject: CHEBI:70839

subject_name: Dasatinib

object_name: adult acute myeloid leukemia with del(5q)


subject: CHEBI:70839

object_name: Adult Acute Promyelocytic Leukemia with PML-RARA


subject: CHEBI:70839

object_name: adult acute myeloid leukemia with inv(16)(p13;q22)


subject: CHEBI:70839

object_name: recurrent adult acute myeloid leukemia


subject: CHEBI:70839

object_name: Untreated Adult Acute Myeloid Leukemia


subject: CHEBI:70839

object_name: adult acute myeloid leukemia with 11q23 (MLL) abnormalities


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:49375


subject: PUBCHEM.COMPOUND:9824461

subject_name: remimazolam

object_name: obstructive sleep apnea syndrome


subject: UMLS:C5446542

subject_name: CD123-specific Targeting Module TM123

object_name: adult acute myeloid leukemia


subject: UMLS:C5446542

object_name: childhood acute myeloid leukemia


subject: UMLS:C5446542

object_name: acute myeloid leukemia


subject: PUBCHEM.COMPOUND:135402036


subject: PUBCHEM.COMPOUND:135402036


subject: PUBCHEM.COMPOUND:135402036


subject: CHEBI:17202

subject_name: Inosinic Acid


subject: CHEBI:17202


subject: CHEBI:17202


subject: CHEBI:58053


subject: CHEBI:58053


subject: CHEBI:58053


subject: CHEBI:190509

subject_name: Imipenem


subject: CHEBI:190509


subject: CHEBI:190509


subject: UMLS:C4745070

subject_name: GSK-3 Inhibitor 9-ING-41

object_name: myelofibrosis


subject: GTOPDB:13718

subject_name: xaluritamig

object_name: Castration-Sensitive Prostate Carcinoma


subject: UNII:ODG03B9M4U

subject_name: XALURITAMIG


subject: UMLS:C5238964

subject_name: Xaluritamig


subject: CHEBI:231614

subject_name: Nivolumab

object_name: refractory malignant neoplasm


subject: UMLS:C2346820


subject: CHEBI:52172

subject_name: Nilotinib

object_name: metastatic neoplasm


subject: CHEBI:52172

object_name: Embolism, Tumor


subject: CHEBI:52172

object_name: Neoplasm Metastasis


subject: CHEBI:52172

object_name: Metastatic Lesion


subject: CHEBI:45783

subject_name: Imatinib


subject: CHEBI:45783


subject: CHEBI:53760

subject_name: Eszopiclone

object_name: Chronic Insomnia


subject: UNII:FYS6T7F842

subject_name: Adalimumab


subject: CHEBI:4445

subject_name: Desflurane

object_name: spinal disease


subject: UNII:105J35OE21

subject_name: Aducanumab

object_name: Cognitive impairment


subject: MESH:D000095983

subject_name: Bacterial Lysates

object_name: respiratory tract infectious disorder


subject: UMLS:C5828311


subject: CHEBI:50730

subject_name: Montelukast

object_name: atopic conjunctivitis


subject: UMLS:C2703111

object_name: Advanced cancer


subject: UNII:4G4Z4676IS

subject_name: buciclovir

object_name: HIV infection


subject: PUBCHEM.COMPOUND:56674991

subject_name: Brincidofovir


subject: CHEBI:17792

subject_name: RX

object_name: elevated lipoprotein (a)


subject: PR:000013771

subject_name: retinal homeobox protein Rx


subject: CHEBI:38545

subject_name: Rosuvastatin

object_name: rectal carcinoma


subject: CHEBI:38545

object_name: rectal cancer


subject: CHEBI:38545

object_name: Childhood Rectal Carcinoma


subject: CHEBI:94531

subject_name: belinostat

object_name: Refractory Hodgkin Lymphoma


subject: CHEBI:94531

object_name: Refractory Childhood Hodgkin Lymphoma


subject: CHEBI:94531

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: CHEBI:94531

object_name: Recurrent Hodgkin Lymphoma


subject: CHEBI:94531

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: CHEBI:94531

object_name: Refractory Breast Carcinoma


subject: CHEBI:94531

object_name: Nodal marginal zone B-cell lymphoma refractory


subject: CHEBI:94531

object_name: Mycosis fungoides refractory


subject: CHEBI:94531

object_name: Breast cancer recurrent


subject: CHEBI:94531

object_name: Metastatic Breast Carcinoma


subject: CHEBI:94531

object_name: breast adenocarcinoma


subject: CHEBI:94531

object_name: Mycosis fungoides recurrent


subject: PUBCHEM.COMPOUND:73005958

subject_name: Carfilzomib

object_name: Non-Hodgkin's lymphoma refractory


subject: PUBCHEM.COMPOUND:73005958


subject: PUBCHEM.COMPOUND:73005958


subject: PUBCHEM.COMPOUND:73005958


subject: PUBCHEM.COMPOUND:73005958

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:73005958

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:73005958

object_name: Recurrent Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:73005958


subject: PUBCHEM.COMPOUND:73005958


subject: PUBCHEM.COMPOUND:73005958

object_name: Recurrent Adult Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:73005958


subject: PUBCHEM.COMPOUND:73005958

object_name: Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:73005958


subject: PUBCHEM.COMPOUND:73005958


subject: PUBCHEM.COMPOUND:73005958


subject: PUBCHEM.COMPOUND:73005958


subject: PUBCHEM.COMPOUND:73005958


subject: PUBCHEM.COMPOUND:73005958


subject: UMLS:C1709429


subject: UMLS:C1709429

object_name: Refractory Hodgkin Lymphoma


subject: UMLS:C1709429

object_name: Refractory Childhood Hodgkin Lymphoma


subject: UMLS:C1709429

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: UMLS:C1709429


subject: UMLS:C1709429


subject: UMLS:C1709429


subject: UMLS:C1709429

object_name: Recurrent Hodgkin Lymphoma


subject: UMLS:C1709429

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: UMLS:C1709429


subject: UMLS:C1709429

object_name: Refractory Breast Carcinoma


subject: UMLS:C1709429


subject: UMLS:C1709429

object_name: Nodal marginal zone B-cell lymphoma refractory


subject: UMLS:C1709429

object_name: Mycosis fungoides refractory


subject: UMLS:C1709429

object_name: Breast cancer recurrent


subject: UMLS:C1709429

object_name: Metastatic Breast Carcinoma


subject: UMLS:C1709429

object_name: breast adenocarcinoma


subject: UMLS:C1709429

object_name: Mycosis fungoides recurrent


subject: CHEBI:173081

subject_name: copanlisib dihydrochloride

object_name: Non-Hodgkin's lymphoma refractory


subject: CHEBI:173081


subject: CHEBI:173081


subject: CHEBI:173081


subject: CHEBI:173081

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: CHEBI:173081

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: CHEBI:173081

object_name: Recurrent Non-Hodgkin Lymphoma


subject: CHEBI:173081


subject: CHEBI:173081


subject: CHEBI:173081

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:173081


subject: CHEBI:173081

object_name: Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: CHEBI:173081


subject: CHEBI:173081

object_name: Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: CHEBI:173081


subject: CHEBI:173081


subject: CHEBI:173081


subject: CHEBI:173081


subject: UMLS:C4528197

subject_name: Copanlisib dihydrochloride


subject: UMLS:C4528197

object_name: Refractory Hodgkin Lymphoma


subject: UMLS:C4528197

object_name: Refractory Childhood Hodgkin Lymphoma


subject: UMLS:C4528197

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: UMLS:C4528197


subject: UMLS:C4528197


subject: UMLS:C4528197


subject: UMLS:C4528197

object_name: Recurrent Hodgkin Lymphoma


subject: UMLS:C4528197

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: UMLS:C4528197


subject: UMLS:C4528197

object_name: Refractory Breast Carcinoma


subject: UMLS:C4528197


subject: UMLS:C4528197

object_name: Nodal marginal zone B-cell lymphoma refractory


subject: UMLS:C4528197


subject: UMLS:C4528197

object_name: Mycosis fungoides refractory


subject: UMLS:C4528197

object_name: Metastatic Breast Carcinoma


subject: UMLS:C4528197

object_name: breast adenocarcinoma


subject: UMLS:C4528197

object_name: Mycosis fungoides recurrent


subject: UNII:4Z63YK6E0E

subject_name: Daratumumab


subject: UNII:4Z63YK6E0E


subject: UNII:4Z63YK6E0E


subject: UNII:4Z63YK6E0E

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: UNII:4Z63YK6E0E

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: UNII:4Z63YK6E0E

object_name: Recurrent Non-Hodgkin Lymphoma


subject: UNII:4Z63YK6E0E


subject: UNII:4Z63YK6E0E


subject: UNII:4Z63YK6E0E

object_name: Recurrent Adult Hodgkin Lymphoma


subject: UNII:4Z63YK6E0E


subject: UNII:4Z63YK6E0E

object_name: Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: UNII:4Z63YK6E0E


subject: UNII:4Z63YK6E0E

object_name: Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: UNII:4Z63YK6E0E


subject: UNII:4Z63YK6E0E

object_name: Breast cancer recurrent


subject: UNII:4Z63YK6E0E


subject: UNII:4Z63YK6E0E


subject: UNII:4Z63YK6E0E


subject: CHEBI:31617

subject_name: fludeoxyglucose (18F)

object_name: Non-Hodgkin's lymphoma refractory


subject: CHEBI:31617

object_name: Refractory Hodgkin Lymphoma


subject: CHEBI:31617

object_name: Refractory Childhood Hodgkin Lymphoma


subject: CHEBI:31617


subject: CHEBI:31617


subject: CHEBI:31617


subject: CHEBI:31617

object_name: Recurrent Hodgkin Lymphoma


subject: CHEBI:31617

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: CHEBI:31617


subject: CHEBI:31617

object_name: Refractory Breast Carcinoma


subject: CHEBI:31617


subject: CHEBI:31617

object_name: Nodal marginal zone B-cell lymphoma refractory


subject: CHEBI:31617


subject: CHEBI:31617

object_name: Mycosis fungoides refractory


subject: CHEBI:31617

object_name: Metastatic Breast Carcinoma


subject: CHEBI:31617

object_name: breast adenocarcinoma


subject: CHEBI:31617

object_name: Mycosis fungoides recurrent


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:175901

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: CHEBI:175901

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UNII:O43472U9X8

subject_name: Obinutuzumab


subject: UNII:O43472U9X8


subject: UNII:O43472U9X8


subject: UNII:O43472U9X8

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: UNII:O43472U9X8


subject: UNII:O43472U9X8


subject: UNII:O43472U9X8

object_name: Recurrent Non-Hodgkin Lymphoma


subject: UNII:O43472U9X8


subject: UNII:O43472U9X8


subject: UNII:O43472U9X8

object_name: Recurrent Adult Hodgkin Lymphoma


subject: UNII:O43472U9X8


subject: UNII:O43472U9X8

object_name: Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: UNII:O43472U9X8


subject: UNII:O43472U9X8

object_name: Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: UNII:O43472U9X8


subject: UNII:O43472U9X8

object_name: Breast cancer recurrent


subject: UNII:O43472U9X8


subject: UNII:O43472U9X8


subject: UNII:O43472U9X8


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: CHEBI:61080

subject_name: Romidepsin

object_name: Non-Hodgkin's lymphoma refractory


subject: CHEBI:61080


subject: CHEBI:61080


subject: CHEBI:61080


subject: CHEBI:61080


subject: CHEBI:61080


subject: CHEBI:61080


subject: CHEBI:61080


subject: UMLS:C0963679


subject: UMLS:C0963679


subject: UMLS:C0963679


subject: UMLS:C0963679


subject: UMLS:C0963679


subject: UMLS:C0963679


subject: UMLS:C0963679


subject: UMLS:C0963679


subject: CHEBI:231601

subject_name: trastuzumab


subject: CHEBI:231601

object_name: Refractory Hodgkin Lymphoma


subject: CHEBI:231601

object_name: Refractory Childhood Hodgkin Lymphoma


subject: CHEBI:231601


subject: CHEBI:231601


subject: CHEBI:231601


subject: CHEBI:231601

object_name: Recurrent Hodgkin Lymphoma


subject: CHEBI:231601

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: CHEBI:231601


subject: CHEBI:231601


subject: CHEBI:231601

object_name: Nodal marginal zone B-cell lymphoma refractory


subject: CHEBI:231601


subject: CHEBI:231601

object_name: Mycosis fungoides refractory


subject: CHEBI:231601


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UMLS:C0338204

subject_name: Herceptin


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UMLS:C1328655

object_name: central nervous system cancer


subject: UMLS:C1328655

object_name: head and neck neoplasm


subject: PUBCHEM.COMPOUND:4456137

subject_name: Epothilone B


subject: PUBCHEM.COMPOUND:4456137


subject: CHEBI:31550

subject_name: Patupilone


subject: CHEBI:31550


subject: DRUGBANK:DB10510

subject_name: Brazil nut

object_name: Increased reactive oxygen species production


subject: DRUGBANK:DB10510

object_name: Inflammation


subject: DRUGBANK:DB10510

object_name: chronic kidney disease


subject: DRUGBANK:DB10510

object_name: Chronic kidney disease stage 3A


subject: DRUGBANK:DB10510

object_name: Chronic kidney disease stage 3B


subject: DRUGBANK:DB10510

object_name: Inflammatory Response


subject: UMLS:C4722537

subject_name: TG02 Citrate

object_name: liver carcinoma


subject: CHEBI:94534

subject_name: olanzapine

object_name: Hematopoietic system--Cancer


subject: CHEBI:94534

object_name: Vomiting in infants AND/OR children


subject: UMLS:C3529783

object_name: chronic pain (diagnosis)


subject: UMLS:C3529783

object_name: Chronic pain


subject: UMLS:C3529783

object_name: Pediatric Disorder


subject: UNII:7ZX1Q9SJ1F

subject_name: NEMVALEUKIN ALFA

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C4287715


subject: CHEBI:50853

subject_name: quantum dot

object_name: fallopian tube neoplasm


subject: GTOPDB:9592

subject_name: tislelizumab

object_name: biliary tract cancer


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: UMLS:C4053664


subject: UMLS:C1609727

subject_name: Artra

object_name: Low back pain


subject: CHEBI:17594

subject_name: Hydroquinone


subject: CHEBI:5001

subject_name: Fenofibrate

object_name: Idiopathic macular telangiectasia type 2


subject: CHEBI:5001

object_name: macular telangiectasia type 2


subject: CHEBI:17115

subject_name: Serine


subject: CHEBI:17115


subject: CHEBI:230430

subject_name: Ulinastatin

object_name: cardiovascular disorder


subject: UNII:OR3S9IF86U

subject_name: urinastatin


subject: CHEMBL.COMPOUND:CHEMBL2108163

subject_name: ULINASTATIN


subject: UMLS:C0077906


subject: CHEBI:109549

subject_name: Ramelteon

object_name: migraine


subject: CHEBI:109549

object_name: migraine with or without aura, susceptibility to, 1


subject: CHEBI:109549

object_name: migraine with aura


subject: CHEBI:109549

object_name: Common Migraine


subject: CHEBI:4495

subject_name: Diazoxide

object_name: type 1 diabetes mellitus 1


subject: CHEBI:190008

subject_name: Tianeptine

object_name: endogenous depression


subject: CHEBI:190008

object_name: major depressive disorder


subject: CHEBI:26710

subject_name: Sodium chloride

object_name: coronary artery disorder


subject: CHEBI:26710

object_name: coronary atherosclerosis


subject: UNII:83G67E21XI

subject_name: Urokinase


subject: UNII:83G67E21XI


subject: UMLS:C0701941

subject_name: Abbokinase


subject: UMLS:C0701941


subject: UMLS:C5552956

subject_name: Direct Oral Anticoagulant

object_name: thrombophilia due to thrombin defect


subject: UMLS:C5552956

object_name: Anticoagulant-induced bleeding


subject: UMLS:C5552956

object_name: pulmonary embolism


subject: CHEBI:16347

subject_name: Levocarnitine

object_name: Myelodysplasia


subject: CHEBI:16347

object_name: Adult Myelodysplastic Syndrome


subject: CHEBI:16347

object_name: childhood myelodysplastic syndrome


subject: CHEBI:16347

object_name: Myelodysplastic Syndrome, CTCAE


subject: CHEBI:135983

subject_name: Teriparatide

object_name: spinal stenosis


subject: UMLS:C2935092

object_name: Alzheimer disease type 1


subject: UMLS:C2935092

object_name: Alzheimer disease


subject: CHEBI:64212

subject_name: Exisulind

object_name: prostate neoplasm


subject: CHEBI:567361

subject_name: Cladribine

object_name: high grade malignant neoplasm


subject: CHEBI:567361

object_name: myelodysplastic syndrome with excess blasts-2


subject: CHEBI:567361

object_name: Chronic Myelomonocytic Leukemia-2


subject: CHEBI:201431

subject_name: Cyclosporin H

object_name: Blasts 10 Percent or More of Bone Marrow Nucleated Cells


subject: CHEBI:201431


subject: CHEBI:201431


subject: CHEBI:201431


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide


subject: CHEBI:28680

subject_name: Cytarabine


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara

object_name: myeloid neoplasm


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:82339

subject_name: Merphalan

object_name: Refractory acute myeloid leukemia


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:28876

subject_name: Melphalan


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: PUBCHEM.COMPOUND:5458171

subject_name: MITOXANTRONE HYDROCHLORIDE


subject: PUBCHEM.COMPOUND:5458171


subject: PUBCHEM.COMPOUND:5458171


subject: PUBCHEM.COMPOUND:5458171


subject: CHEBI:50729

subject_name: Mitoxantrone


subject: CHEBI:50729


subject: CHEBI:50729


subject: CHEBI:50729


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:9168

subject_name: Sirolimus


subject: CHEBI:9168


subject: CHEBI:9168


subject: CHEBI:9168


subject: CHEBI:9168


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: malnutrition


subject: UMLS:C0030940

subject_name: Peptide Hydrolases

object_name: pancreatic neoplasm


subject: UMLS:C0030940

object_name: exocrine pancreatic carcinoma


subject: UMLS:C0030940

object_name: malignant pancreatic neoplasm


subject: UMLS:C0030940


subject: UMLS:C3540759

subject_name: Proteolytic enzymes for treatment of wounds and ulcers


subject: UMLS:C3540759


subject: UMLS:C3540759


subject: UMLS:C3540759


subject: PUBCHEM.COMPOUND:105162

object_name: Parkinsonism


subject: CHEBI:23359

subject_name: colchicine

object_name: myocardial ischemia


subject: CHEBI:91368

subject_name: Enzastaurin

object_name: primary cutaneous T-cell non-Hodgkin lymphoma


subject: CHEBI:91368

object_name: primary cutaneous T-cell lymphoma


subject: CHEBI:84040

object_name: Cerebral Blood Flow


subject: CHEBI:84040

object_name: Overweight and obesity


subject: CHEBI:36002

subject_name: cis-resveratrol


subject: CHEBI:36002


subject: CHEBI:27881

subject_name: resveratrol


subject: CHEBI:27881


subject: CHEBI:9943

subject_name: Venlafaxine

object_name: prostate carcinoma


subject: CHEBI:9943

object_name: prostate cancer


subject: CHEBI:10033

subject_name: Warfarin

object_name: osteoarthritis, knee


subject: CHEBI:6933

subject_name: Midodrine

object_name: Acute-On-Chronic Liver Failure


subject: CHEBI:6933

object_name: acute-on-chronic liver failure


subject: RXCUI:57773

subject_name: Unasyn

object_name: chorioamnionitis


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: Biliary carcinoma


subject: PUBCHEM.COMPOUND:135565596

subject_name: Copanlisib

object_name: cholangiocarcinoma


subject: PUBCHEM.COMPOUND:135565596


subject: PUBCHEM.COMPOUND:135565596

object_name: gallbladder carcinoma


subject: PUBCHEM.COMPOUND:135565596

object_name: digestive system neoplasm


subject: PUBCHEM.COMPOUND:135565596

object_name: Neoplasm of the gastrointestinal tract


subject: CHEBI:173077


subject: CHEBI:173077


subject: CHEBI:173077


subject: CHEBI:173077


subject: CHEBI:173077


subject: CHEBI:175901


subject: CHEBI:71200

subject_name: Tofacitinib

object_name: glioblastoma


subject: CHEBI:71200

object_name: Childhood Glioblastoma


subject: CHEBI:71200

object_name: adult glioblastoma


subject: CHEBI:90237

subject_name: Tandutinib


subject: CHEBI:90237


subject: CHEBI:90237

object_name: Disseminated Malignant Neoplasm


subject: CHEBI:90237

object_name: Embolism, Tumor


subject: CHEBI:90237

object_name: Neoplasm Metastasis


subject: UMLS:C2830100

object_name: insomnia


subject: UMLS:C2830100

object_name: Insomnia, CTCAE 3.0


subject: UMLS:C2830100

object_name: Insomnia, CTCAE 5.0


subject: CHEBI:50848

subject_name: Loteprednol

object_name: Eye Pain, CTCAE 5.0


subject: CHEBI:50848

object_name: Eye Pain, CTCAE 3.0


subject: CHEBI:50848

object_name: Ocular pain


subject: PUBCHEM.COMPOUND:3962

object_name: ovarian cancer


subject: PUBCHEM.COMPOUND:3962

object_name: ovarian neoplasm


subject: PUBCHEM.COMPOUND:3962

object_name: ovarian carcinoma


subject: CHEBI:40303

subject_name: Lovastatin


subject: CHEBI:40303


subject: CHEBI:40303


subject: CHEBI:231614

subject_name: Nivolumab

object_name: refractory cytopenia of childhood


subject: UMLS:C2346820


subject: CHEBI:5775

subject_name: Hydralazine

object_name: rectal carcinoma


subject: CHEBI:5775

object_name: rectal cancer


subject: CHEBI:5775

object_name: Childhood Rectal Carcinoma


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin

object_name: Metastatic Breast Carcinoma


subject: UNII:M89N0Q7EQR

object_name: Metastatic malignant neoplasm to pancreas


subject: UNII:M89N0Q7EQR

object_name: metastatic colorectal cancer


subject: PR:000001379


subject: PR:000001379


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:32016

subject_name: Pirfenidone

object_name: non-small cell lung carcinoma


subject: CHEBI:32016

object_name: Advanced cancer


subject: CHEBI:32016

object_name: squamous cell lung carcinoma


subject: CHEBI:32016

object_name: Secondary malignant neoplasm of lung


subject: CHEBI:32016

object_name: Nonsquamous nonsmall cell neoplasm of lung


subject: CHEBI:91899

object_name: engraftment syndrome


subject: CHEBI:3207

subject_name: Budesonide


subject: CHEBI:71954

subject_name: Buparlisib

object_name: thyroid gland carcinoma


subject: CHEBI:71954

object_name: thyroid cancer


subject: UMLS:C5205493

subject_name: Pucotenlimab

object_name: Advanced Malignant Solid Neoplasm


subject: UNII:90ZX3Q3FR7

subject_name: Risankizumab

object_name: ankylosing spondylitis


subject: UMLS:C4078397


subject: UNII:82JB1524Q6

subject_name: Ombrabulin


subject: UMLS:C0910081


subject: CHEBI:149509

object_name: glucose intolerance


subject: CHEBI:149509

object_name: Glucose Intolerance, CTCAE


subject: CHEBI:3347

subject_name: Candesartan


subject: CHEBI:3347


subject: UMLS:C0358855

subject_name: Nicotine Transdermal Patch

object_name: nicotine dependence - cigarettes


subject: UMLS:C2348288

subject_name: Dietary Zinc

object_name: Dietary selenium deficiency


subject: UMLS:C2348288

object_name: Dietary zinc deficiency


subject: CHEBI:29105

subject_name: Velmanase alfa


subject: CHEBI:29105


subject: CHEBI:27363

subject_name: Zinc


subject: CHEBI:27363


subject: UMLS:C3541396

subject_name: Zinc Supplements


subject: UMLS:C3541396


subject: UMLS:C3714650

subject_name: Zinc Drug Class


subject: UMLS:C3714650


subject: CHEBI:90623

object_name: plasma cell myeloma


subject: CHEBI:404903

subject_name: Ertapenem

object_name: diabetic foot


subject: CHEBI:404903

object_name: osteomyelitis


subject: CHEBI:142708


subject: CHEBI:142708


subject: PUBCHEM.COMPOUND:54686904

subject_name: tigecycline


subject: PUBCHEM.COMPOUND:54686904


subject: CHEBI:149836

subject_name: Tigecycline


subject: CHEBI:149836


subject: CHEBI:6904

subject_name: Metoprolol

object_name: atrial flutter


subject: CHEBI:6904

object_name: Atrial Flutter by ECG Finding


subject: CHEBI:6904

object_name: Atrial Flutter, CTCAE


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: pancreatic adenocarcinoma


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: PUBCHEM.COMPOUND:3367

object_name: ovarian serous adenocarcinoma


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367

object_name: ovarian adenocarcinoma


subject: PUBCHEM.COMPOUND:3367

object_name: colorectal neoplasm


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: UMLS:C5446566

subject_name: B-cell Lymphoma-2 Inhibitor BGB-11417

object_name: B-cell chronic lymphocytic leukemia


subject: UMLS:C5446566

object_name: leukemia


subject: UMLS:C5446566

object_name: childhood leukemia


subject: UMLS:C5446566

object_name: adult lymphoma


subject: UMLS:C5446566

object_name: lymphoma


subject: UMLS:C5446566

object_name: pediatric lymphoma


subject: UMLS:C5446566

object_name: Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma


subject: UMLS:C5446566

object_name: Recurrent Chronic Lymphoid Leukemia


subject: CHEBI:6339

subject_name: Etoricoxib

object_name: Fasting


subject: UMLS:C1645682

subject_name: B12-Folic Acid

object_name: cardiovascular disorder


subject: CHEBI:17045

subject_name: Nitrous oxide


subject: CHEBI:4911

subject_name: Etoposide

object_name: Metastatic human epidermal growth factor 2 positive carcinoma of breast


subject: CHEBI:231601

subject_name: trastuzumab


subject: UNII:SE2KH7T06F


subject: UMLS:C0338204

subject_name: Herceptin


subject: UMLS:C0358855

subject_name: Nicotine Transdermal Patch

object_name: coronary artery disorder


subject: UNII:4Z63YK6E0E

subject_name: Daratumumab

object_name: hemolytic anemia


subject: UNII:4Z63YK6E0E

object_name: non-autoimmune hemolytic anemia


subject: UMLS:C0499033

subject_name: Injection, hyaluronidase, up to 150 units administered


subject: UMLS:C0499033


subject: UMLS:C5203330

subject_name: Hyaluronidase Liquid Injection


subject: UMLS:C5203330


subject: PUBCHEM.COMPOUND:91820602

subject_name: Hyaluronidase


subject: PUBCHEM.COMPOUND:91820602


subject: UMLS:C0683092

subject_name: intravenous drug

object_name: pain agnosia


subject: UMLS:C0683092

object_name: Pain insensitivity


subject: CHEBI:4974

subject_name: Famciclovir

object_name: Recurrent genital herpes


subject: PUBCHEM.COMPOUND:90488848

object_name: Nephrotic syndrome in children


subject: CHEBI:3892

subject_name: Corticotropin


subject: UMLS:C5557417

subject_name: Enlonstobart

object_name: triple-negative breast carcinoma


subject: UMLS:C5557417

object_name: Triple-Negative Breast Cancer Finding


subject: PUBCHEM.COMPOUND:5300

subject_name: STREPTOZOTOCIN

object_name: Zollinger-Ellison syndrome


subject: PUBCHEM.COMPOUND:5300

object_name: Neoplasm Metastasis


subject: PUBCHEM.COMPOUND:5300

object_name: pancreatic neuroendocrine neoplasm


subject: PUBCHEM.COMPOUND:5300

object_name: insulinoma


subject: CHEBI:9288

subject_name: Streptozocin


subject: CHEBI:9288


subject: CHEBI:9288


subject: CHEBI:9288


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil


subject: PUBCHEM.COMPOUND:14907381


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus


subject: CHEBI:190410


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: UMLS:C0885555

subject_name: Magnesia sulphurica, epsom salt, Homeopathic preparation

object_name: Perineal injury


subject: CHEBI:32599


subject: CHEBI:131389

subject_name: magnesium citrate

object_name: gestational diabetes


subject: CHEBI:131391


subject: CHEBI:48814

subject_name: Chloral

object_name: insomnia


subject: CHEBI:48814

object_name: Insomnia, CTCAE 3.0


subject: CHEBI:48814

object_name: Insomnia, CTCAE 5.0


subject: CHEBI:48814

object_name: Chronic Insomnia


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: bladder tumor


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: CHEBI:37956

subject_name: histamine antagonist


subject: UMLS:C0740098

subject_name: Antihistamine brand of Diphenhydramine


subject: UMLS:C0019592

subject_name: Histamine H1 Antagonists


subject: UMLS:C3536809

subject_name: Antihistamine [EPC]


subject: CHEBI:135905

subject_name: Terlipressin

object_name: Hepatic ascites


subject: CHEBI:134709

subject_name: Pitolisant

object_name: substance abuse


subject: UNII:H3598Y1TLJ

subject_name: VITESPEN

object_name: pancreatic neoplasm


subject: UNII:H3598Y1TLJ

object_name: exocrine pancreatic carcinoma


subject: UNII:H3598Y1TLJ

object_name: malignant pancreatic neoplasm


subject: UMLS:C0935952

subject_name: Oncophage


subject: UMLS:C0935952


subject: UMLS:C0935952


subject: CHEBI:85980

subject_name: Eluxadoline

object_name: Diarrhea due to diabetes mellitus


subject: CHEBI:85980

object_name: type 2 diabetes mellitus


subject: CHEBI:85980

object_name: Diabetes


subject: CHEBI:85980

object_name: diabetes mellitus


subject: CHEBI:9907

subject_name: ursodiol

object_name: Overweight and obesity


subject: CHEBI:9907

object_name: acute lymphoblastic leukemia


subject: CHEBI:75998

subject_name: Trametinib

object_name: prostate cancer


subject: MESH:C478920

object_name: osteoarthritis, knee


subject: UNII:DEW6X41BEK

subject_name: Tildrakizumab

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:8389

subject_name: conjugated estrogens

object_name: Prediabetes


subject: PUBCHEM.COMPOUND:45357473

subject_name: Estratab


subject: CHEBI:135947

subject_name: Bazedoxifene


subject: CHEBI:3663

object_name: Menopause present (finding)


subject: CHEBI:3663

object_name: Menopause


subject: CHEBI:3663


subject: CHEBI:33369

subject_name: cerium


subject: CHEBI:33369


subject: CHEBI:33369


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: patellofemoral pain syndrome


subject: PUBCHEM.COMPOUND:66586232

object_name: vulvovaginal candidiasis


subject: CHEBI:3614

subject_name: Chlorhexidine


subject: CHEBI:78887

subject_name: Tirapazamine

object_name: Cervical carcinoma stage IIA


subject: CHEBI:78887

object_name: Stage IIA Cervical Cancer AJCC v6


subject: CHEBI:78887

object_name: Stage IIA Cervical Cancer AJCC v8


subject: CHEBI:78887

object_name: Stage IIA Cervical Cancer AJCC v7


subject: CHEBI:78887

object_name: Stage IVA Cervical Cancer AJCC v8


subject: CHEBI:78887

object_name: Stage IVA Cervical Cancer AJCC v6 and v7


subject: CHEBI:78887

object_name: Cervical carcinoma stage IVA


subject: CHEBI:78887

object_name: stage III cervical cancer


subject: CHEBI:78887

object_name: Stage III Cervical Cancer AJCC v6 and v7


subject: CHEBI:78887

object_name: Stage III Cervical Cancer AJCC v8


subject: CHEBI:78887

object_name: Stage IB Cervical Cancer AJCC v8


subject: CHEBI:78887

object_name: stage IB cervical cancer


subject: CHEBI:78887

object_name: Stage IB Cervical Cancer AJCC v6 and v7


subject: CHEBI:78887

object_name: Stage IIB Cervical Cancer AJCC v6 and v7


subject: CHEBI:78887

object_name: Cervical carcinoma stage IIB


subject: CHEBI:78887

object_name: Stage IIB Cervical Cancer AJCC v8


subject: CHEBI:78887

object_name: cervical adenocarcinoma


subject: CHEBI:78887

object_name: cervical squamous cell carcinoma


subject: CHEBI:78887

object_name: cervical adenosquamous carcinoma


subject: CHEBI:232155

subject_name: 2-amino-6-diazo-5-oxohexanoic acid

object_name: cerebral malaria


subject: CHEBI:138889


subject: UMLS:C0012020

subject_name: Diazooxonorleucine


subject: CHEBI:10022

subject_name: deoxynivalenol


subject: CHEMBL.COMPOUND:CHEMBL4640542

object_name: Childhood Solid Neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4640542

object_name: Adult Solid Neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4640542

object_name: Solid Neoplasm


subject: CHEBI:3219

subject_name: Bupropion

object_name: Schizophrenia Spectrum and Other Psychotic Disorders


subject: UMLS:C2986396

object_name: adult glioblastoma


subject: UMLS:C2986396

object_name: glioblastoma


subject: UMLS:C2986396

object_name: Brain Stem Glioblastoma


subject: UMLS:C2986396

object_name: brain glioblastoma


subject: UMLS:C2986396

object_name: Intracranial glioma


subject: DRUGBANK:DB17293

subject_name: Hiltonol


subject: DRUGBANK:DB17293


subject: UNII:7KYP9TKT70

subject_name: poly ICLC


subject: UNII:7KYP9TKT70


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:349552KRHK

subject_name: Simendan

object_name: stroke disorder


subject: UNII:349552KRHK

object_name: cerebrovascular disorder


subject: UNII:349552KRHK

object_name: Stroke (heart beat)


subject: UNII:349552KRHK

object_name: Stroke, CTCAE


subject: UNII:349552KRHK

object_name: transient ischemic attack


subject: CHEBI:193746


subject: CHEBI:193746


subject: CHEBI:193746


subject: CHEBI:193746


subject: CHEBI:193746


subject: CHEBI:50567

subject_name: Levosimendan


subject: CHEBI:50567


subject: CHEBI:50567


subject: CHEBI:50567


subject: CHEBI:50567


subject: CHEBI:57858

subject_name: atropinium

object_name: ventilator-associated pneumonia


subject: CHEBI:92712

subject_name: ENDO-ATROPINE


subject: CHEBI:91541


subject: UMLS:C1161352

subject_name: Atropinum, atropine


subject: UMLS:C0006055

subject_name: Botulinum Toxins

object_name: Orofacial dystonia


subject: UMLS:C0019120

subject_name: Hemostatic Agents

object_name: prostate carcinoma


subject: UMLS:C0019120

object_name: prostate cancer


subject: GTOPDB:13826

subject_name: pegcetacoplan

object_name: Delayed Graft Function


subject: GTOPDB:13826

object_name: end stage renal failure


subject: GTOPDB:13826

object_name: Chronic uremia


subject: UNII:TO3JYR3BOU

subject_name: Pegcetacoplan


subject: UNII:TO3JYR3BOU


subject: UNII:TO3JYR3BOU


subject: MESH:C572820

subject_name: Aquamin

object_name: Halitosis


subject: CHEBI:95067

subject_name: Iniparib

object_name: cancer


subject: CHEBI:49005

subject_name: Deferasirox

object_name: Rare anemia


subject: UMLS:C2825233

subject_name: systemic steroids

object_name: vitiligo-associated multiple autoimmune disease susceptibility 1


subject: UMLS:C2825233

object_name: vitiligo


subject: PUBCHEM.COMPOUND:10752953


subject: PUBCHEM.COMPOUND:10752953


subject: PUBCHEM.COMPOUND:10752953

object_name: Stage II Prostate Cancer AJCC v6


subject: PUBCHEM.COMPOUND:10752953

object_name: Stage II Prostate Cancer AJCC v8


subject: PUBCHEM.COMPOUND:10752953

object_name: Carcinoma of the prostate stage II


subject: PUBCHEM.COMPOUND:10752953

object_name: Stage II Prostate Cancer AJCC v7


subject: PUBCHEM.COMPOUND:10752953

object_name: Stage I Prostate Cancer AJCC v6


subject: PUBCHEM.COMPOUND:10752953

object_name: Prostate cancer stage I


subject: PUBCHEM.COMPOUND:10752953

object_name: Stage I Prostate Cancer AJCC v8


subject: PUBCHEM.COMPOUND:10752953

object_name: Stage I Prostate Cancer AJCC v7


subject: PUBCHEM.COMPOUND:10752953

object_name: prostate adenocarcinoma


subject: CHEBI:50182

subject_name: ARUNDINE

object_name: prostate carcinoma


subject: CHEBI:50182

object_name: prostate cancer


subject: CHEBI:50182


subject: CHEBI:50182


subject: CHEBI:50182


subject: CHEBI:50182


subject: CHEBI:50182


subject: CHEBI:50182


subject: CHEBI:50182


subject: CHEBI:50182


subject: CHEBI:50182


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma


subject: UNII:LDJ89SS0YG

subject_name: Mosunetuzumab


subject: UMLS:C4329313


subject: UNII:KG6VO684Z6

subject_name: Polatuzumab vedotin


subject: UMLS:C3641728


subject: CHEMBL.COMPOUND:CHEMBL3707352

subject_name: policosanol

object_name: coronary artery disorder


subject: CHEMBL.COMPOUND:CHEMBL3707352

object_name: coronary atherosclerosis


subject: CHEBI:64019

subject_name: Nebivolol

object_name: Childhood Breast Carcinoma


subject: CHEBI:64019

object_name: breast carcinoma


subject: CHEBI:64019

object_name: breast cancer


subject: CHEBI:64019

object_name: cardiotoxicity


subject: CHEBI:64019

object_name: Effects of chemotherapy


subject: CHEBI:64019

object_name: diffuse large B-cell lymphoma


subject: CHEBI:64019

object_name: Abnormal left ventricular function


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Childhood Desmoplastic Small Round Cell Tumor


subject: UNII:2S9ZZM9Q9V

object_name: desmoplastic small round cell tumor


subject: UNII:2S9ZZM9Q9V

object_name: Adult Desmoplastic Small Round Cell Tumor


subject: UNII:2S9ZZM9Q9V

object_name: Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside


subject: PUBCHEM.COMPOUND:131769963


subject: PUBCHEM.COMPOUND:131769963


subject: PUBCHEM.COMPOUND:131769963

object_name: Ewing sarcoma


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:79699

subject_name: Temsirolimus


subject: CHEBI:79699


subject: CHEBI:79699


subject: CHEBI:79699


subject: CHEBI:79699


subject: CHEBI:132922

object_name: Axial Spondyloarthritis


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:5855

subject_name: Ibuprofen


subject: UMLS:C0770246

subject_name: PROTEIN SUPPLEMENTS

object_name: Burn injury


subject: UMLS:C0770246

object_name: Burn, CTCAE


subject: CHEBI:9654

subject_name: Trazodone

object_name: Poor quality sleep


subject: CHEBI:9654

object_name: opiate dependence


subject: CHEBI:166975

subject_name: soybean oil

object_name: Antiphospholipid syndrome in pregnancy


subject: DRUGBANK:DB09422

subject_name: Soybean oil


subject: GTOPDB:8323

subject_name: monalizumab

object_name: B-cell chronic lymphocytic leukemia


subject: UNII:3ZXZ2V0588


subject: UMLS:C3896730


subject: CHEBI:145588

object_name: Rhizarthrosis


subject: PUBCHEM.COMPOUND:168359761

subject_name: Chondroitin sulfate


subject: CHEBI:145591


subject: CHEBI:7986

subject_name: Pentoxifylline

object_name: bipolar disorder


subject: CHEBI:7986

object_name: bipolar depression


subject: UMLS:C3714648

subject_name: Vitamin K Drug Class

object_name: Vascular calcification


subject: UMLS:C3714648

object_name: Inflammation


subject: UMLS:C3541380

subject_name: Vitamin K containing hemostatics


subject: UMLS:C3541380


subject: CHEBI:28384

subject_name: vitamin K


subject: CHEBI:18067

subject_name: Phylloquinone


subject: UMLS:C2936884

subject_name: Vitamin K [EPC]


subject: UMLS:C2936884


subject: UMLS:C5690683

object_name: epidermolysis bullosa simplex 1B, generalized intermediate


subject: CHEBI:51380

subject_name: Doxylamine

object_name: Vomiting of pregnancy


subject: UMLS:C3714638

subject_name: Pyridoxine Drug Class


subject: CHEBI:27306

subject_name: vitamin B6


subject: CHEBI:31174

subject_name: Adapalene

object_name: common wart


subject: CHEBI:119915

subject_name: Fentanyl

object_name: Visceral Pain


subject: CHEBI:50731

subject_name: morphine sulfate pentahydrate

object_name: Pruritus caused by drug


subject: CHEBI:17303

subject_name: Morphine


subject: UMLS:C0731161

subject_name: Glucagon Lilly

object_name: hypoglycemia


subject: UMLS:C0731161

object_name: Blood glucose below reference range (finding)


subject: UMLS:C0731161

object_name: Hypoglycemia, CTCAE


subject: CHEBI:84094

subject_name: testosterone sulfate

object_name: colorectal cancer


subject: CHEBI:84094

object_name: colorectal carcinoma


subject: CHEBI:84094

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C4721537

subject_name: Therapeutic Testosterone


subject: UMLS:C4721537


subject: UMLS:C4721537


subject: CHEBI:17347

subject_name: Testosterone


subject: CHEBI:17347


subject: CHEBI:17347


subject: CHEBI:5801

subject_name: Hydroxychloroquine

object_name: Arthralgia


subject: CHEBI:5801

object_name: Arthralgia, CTCAE


subject: CHEBI:5801

object_name: arthritis


subject: CHEBI:5801

object_name: Arthritis, CTCAE


subject: CHEBI:174615

object_name: Stage I Adult Hodgkin Lymphoma


subject: CHEBI:174615

object_name: Stage II Adult Hodgkin Lymphoma


subject: CHEBI:174615

object_name: Stage IV Adult Hodgkin Lymphoma


subject: CHEBI:174615

object_name: Stage III Adult Hodgkin Lymphoma


subject: CHEBI:174615

object_name: Stage I Childhood Hodgkin Lymphoma


subject: CHEBI:174615

object_name: Stage II Childhood Hodgkin Lymphoma


subject: CHEBI:174615

object_name: Stage IV Childhood Hodgkin Lymphoma


subject: CHEBI:174615

object_name: Stage III Childhood Hodgkin Lymphoma


subject: CHEBI:174615

object_name: Stage I Childhood Large Cell Lymphoma


subject: CHEBI:174615

object_name: Stage IV Childhood Large Cell Lymphoma


subject: CHEBI:174615

object_name: Stage II Childhood Large Cell Lymphoma


subject: CHEBI:174615

object_name: Stage III Childhood Large Cell Lymphoma


subject: CHEBI:174615

object_name: Stage I Childhood Lymphoblastic Lymphoma


subject: CHEBI:174615

object_name: Stage IV Childhood Lymphoblastic Lymphoma


subject: CHEBI:174615

object_name: Stage II Childhood Lymphoblastic Lymphoma


subject: CHEBI:174615

object_name: Stage III Childhood Lymphoblastic Lymphoma


subject: CHEBI:174615

object_name: Stage I Childhood Burkitt Lymphoma


subject: CHEBI:174615

object_name: Stage IV Childhood Burkitt Lymphoma


subject: CHEBI:174615

object_name: Stage II Childhood Burkitt Lymphoma


subject: CHEBI:174615

object_name: Stage III Childhood Burkitt Lymphoma


subject: CHEBI:174615

object_name: Stage I Childhood Anaplastic Large Cell Lymphoma


subject: CHEBI:174615

object_name: Stage II Childhood Anaplastic Large Cell Lymphoma


subject: CHEBI:174615

object_name: Stage IV Childhood Anaplastic Large Cell Lymphoma


subject: CHEBI:174615

object_name: Stage III Childhood Anaplastic Large Cell Lymphoma


subject: CHEBI:174615

object_name: Childhood Grade III Lymphomatoid Granulomatosis


subject: CHEBI:174615

object_name: Adult Grade III Lymphomatoid Granulomatosis


subject: CHEBI:174615

object_name: Stage IIIB Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: CHEBI:174615

object_name: Stage IIIA Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: CHEBI:174615

object_name: Stage IVA Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: CHEBI:174615

object_name: Stage IVB Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: CHEBI:174615

object_name: Stage IIB Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: CHEBI:174615

object_name: Stage IIA Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: CHEBI:174615

object_name: Stage IB Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: CHEBI:174615

object_name: Stage IA Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: CHEBI:28901

subject_name: Busulfan

object_name: Stage I Adult Hodgkin Lymphoma


subject: CHEBI:28901

object_name: Stage II Adult Hodgkin Lymphoma


subject: CHEBI:28901

object_name: Stage IV Adult Hodgkin Lymphoma


subject: CHEBI:28901

object_name: Stage III Adult Hodgkin Lymphoma


subject: CHEBI:28901

object_name: Stage I Childhood Hodgkin Lymphoma


subject: CHEBI:28901

object_name: Stage II Childhood Hodgkin Lymphoma


subject: CHEBI:28901

object_name: Stage IV Childhood Hodgkin Lymphoma


subject: CHEBI:28901

object_name: Stage III Childhood Hodgkin Lymphoma


subject: CHEBI:28901

object_name: Stage I Childhood Large Cell Lymphoma


subject: CHEBI:28901

object_name: Stage IV Childhood Large Cell Lymphoma


subject: CHEBI:28901

object_name: Stage II Childhood Large Cell Lymphoma


subject: CHEBI:28901

object_name: Stage III Childhood Large Cell Lymphoma


subject: CHEBI:28901

object_name: Stage I Childhood Lymphoblastic Lymphoma


subject: CHEBI:28901

object_name: Stage IV Childhood Lymphoblastic Lymphoma


subject: CHEBI:28901

object_name: Stage II Childhood Lymphoblastic Lymphoma


subject: CHEBI:28901

object_name: Stage III Childhood Lymphoblastic Lymphoma


subject: CHEBI:28901

object_name: Stage I Childhood Burkitt Lymphoma


subject: CHEBI:28901

object_name: Stage IV Childhood Burkitt Lymphoma


subject: CHEBI:28901

object_name: Stage II Childhood Burkitt Lymphoma


subject: CHEBI:28901

object_name: Stage III Childhood Burkitt Lymphoma


subject: CHEBI:28901

object_name: Stage I Childhood Anaplastic Large Cell Lymphoma


subject: CHEBI:28901

object_name: Stage II Childhood Anaplastic Large Cell Lymphoma


subject: CHEBI:28901

object_name: Stage IV Childhood Anaplastic Large Cell Lymphoma


subject: CHEBI:28901

object_name: Stage III Childhood Anaplastic Large Cell Lymphoma


subject: CHEBI:28901

object_name: Childhood Grade III Lymphomatoid Granulomatosis


subject: CHEBI:28901

object_name: Adult Grade III Lymphomatoid Granulomatosis


subject: CHEBI:28901

object_name: Stage IIIB Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: CHEBI:28901

object_name: Stage IIIA Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: CHEBI:28901

object_name: Stage IVA Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: CHEBI:28901

object_name: Stage IVB Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: CHEBI:28901

object_name: Stage IIB Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: CHEBI:28901

object_name: Stage IIA Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: CHEBI:28901

object_name: Stage IB Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: CHEBI:28901

object_name: Stage IA Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4911

subject_name: Etoposide

object_name: Stage I Adult Lymphoblastic Lymphoma


subject: CHEBI:4911

object_name: Stage IV Adult Lymphoblastic Lymphoma


subject: CHEBI:4911

object_name: Stage III Adult Lymphoblastic Lymphoma


subject: CHEBI:4911

object_name: Stage I Childhood Lymphoblastic Lymphoma


subject: CHEBI:4911

object_name: Stage IV Childhood Lymphoblastic Lymphoma


subject: CHEBI:4911

object_name: Stage II Childhood Lymphoblastic Lymphoma


subject: CHEBI:4911

object_name: Stage III Childhood Lymphoblastic Lymphoma


subject: CHEBI:4911

object_name: Ann Arbor Stage II Contiguous Adult Lymphoblastic Lymphoma


subject: CHEBI:4911

object_name: Ann Arbor Stage II Non-Contiguous Adult Lymphoblastic Lymphoma


subject: CHEBI:4911

object_name: Stage I Adult Burkitt Lymphoma


subject: CHEBI:4911

object_name: Stage I Childhood Anaplastic Large Cell Lymphoma


subject: CHEBI:4911

object_name: Stage IV Adult Burkitt Lymphoma


subject: CHEBI:4911

object_name: Ann Arbor Stage II Contiguous Adult Burkitt Lymphoma


subject: CHEBI:4911

object_name: Stage III Adult Burkitt Lymphoma


subject: CHEBI:4911

object_name: Ann Arbor Stage II Non-Contiguous Adult Burkitt Lymphoma


subject: CHEBI:4911

object_name: Adult T-cell lymphoma/leukaemia stage I


subject: CHEBI:4911

object_name: Adult T-cell lymphoma/leukaemia stage II


subject: CHEBI:4911

object_name: Adult T-cell lymphoma/leukaemia stage IV


subject: CHEBI:4911

object_name: Adult T-cell lymphoma/leukaemia stage III


subject: CHEBI:4911

object_name: Stage IIIB Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: CHEBI:4911

object_name: Stage IIIA Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: CHEBI:4911

object_name: Stage IVA Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: CHEBI:4911

object_name: Stage IVB Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: CHEBI:4911

object_name: Stage IIB Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: CHEBI:4911

object_name: Stage IIA Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: CHEBI:4911

object_name: Stage IB Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: CHEBI:4911

object_name: Stage IA Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Anatomic Stage I Breast Cancer AJCC v8


subject: UNII:K16AIQ8CTM

subject_name: Pertuzumab


subject: UMLS:C4287951

subject_name: pUMVC3-IGFBP2-HER2-IGF1R Plasmid DNA Vaccine


subject: CHEBI:135949

subject_name: Ambrisentan

object_name: baetz-greenwalt syndrome


subject: CHEBI:135949

object_name: hypoplastic left heart syndrome


subject: UMLS:C5783522

subject_name: Anti-HER2 Antibody-drug Conjugate JSKN003

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:27446

subject_name: Penicillin V

object_name: infectious disease


subject: CHEBI:15377

subject_name: Water

object_name: Acute Pain


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: Recurrent Childhood Gliosarcoma


subject: UNII:52CMI0WC3Y

object_name: Recurrent Gliosarcoma


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: CHEBI:72317

subject_name: Cabozantinib

object_name: Recurrent Childhood Glioblastoma


subject: CHEBI:72317

object_name: Recurrent Glioblastoma


subject: CHEBI:72317


subject: CHEBI:72317


subject: UMLS:C0723575

subject_name: T-Diet

object_name: severe insufficient nutrition


subject: CHEMBL.COMPOUND:CHEMBL2108161

subject_name: TUBERCULIN

object_name: leprosy


subject: UMLS:C0041289

subject_name: tuberculin


subject: UMLS:C0034131

subject_name: Tubersol


subject: UNII:Q46947FE7K

subject_name: Peginterferon alfa-2a

object_name: Childhood Breast Carcinoma


subject: UNII:Q46947FE7K

object_name: breast carcinoma


subject: UNII:Q46947FE7K

object_name: breast cancer


subject: UNII:Q46947FE7K

object_name: Disseminated Malignant Neoplasm


subject: UNII:Q46947FE7K

object_name: Embolism, Tumor


subject: UNII:Q46947FE7K

object_name: Neoplasm Metastasis


subject: UNII:QX45B99R3J

subject_name: Mavacamten

object_name: Left ventricular outflow tract obstruction


subject: CHEBI:16296

subject_name: D-Tryptophan

object_name: Alzheimer disease


subject: CHEBI:27897

subject_name: tryptophan


subject: CHEBI:4753

subject_name: Echothiophate

object_name: myopia


subject: UNII:O43472U9X8

subject_name: Obinutuzumab

object_name: graft versus host disease


subject: UNII:DLG4EML025

subject_name: Secukinumab

object_name: vitiligo-associated multiple autoimmune disease susceptibility 1


subject: UNII:DLG4EML025

object_name: vitiligo


subject: UMLS:C3827038

subject_name: IGF-methotrexate Conjugate

object_name: digestive system cancer


subject: UMLS:C3827038

object_name: Genitourinary Cancer


subject: UMLS:C3827038

object_name: female reproductive organ cancer


subject: UMLS:C3827038


subject: UMLS:C3827038


subject: UMLS:C3827038


subject: UMLS:C3827038

object_name: brain cancer


subject: UMLS:C3827038

object_name: brain neoplasm


subject: UMLS:C3827038

object_name: melanoma


subject: CHEBI:28787

subject_name: Nitroglycerin

object_name: retinoblastoma


subject: CHEBI:74947

subject_name: Thalidomide

object_name: Transfusion dependent thalassaemia beta


subject: PUBCHEM.COMPOUND:66660570

subject_name: Evogliptin

object_name: metabolic bone disorder


subject: CHEBI:233362

subject_name: Abemaciclib

object_name: Metastatic Hormone Receptor-Positive Breast Carcinoma


subject: CHEBI:233362

object_name: Metastatic HER2-Negative Breast Carcinoma


subject: CHEBI:233362

object_name: Locally Advanced Unresectable Hormone Receptor-Positive Breast Carcinoma


subject: CHEBI:233362

object_name: Locally Advanced Unresectable HER2-Negative Breast Carcinoma


subject: CHEBI:2704

subject_name: Anastrozole


subject: CHEBI:2704


subject: CHEBI:2704


subject: CHEBI:2704


subject: CHEBI:4953

subject_name: Exemestane


subject: CHEBI:4953


subject: CHEBI:4953


subject: CHEBI:4953


subject: UNII:3I798OGQ8B

subject_name: Fluorofuranylnorprogesterone F-18


subject: UNII:3I798OGQ8B


subject: UNII:3I798OGQ8B


subject: UNII:3I798OGQ8B


subject: UNII:3I798OGQ8B

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: UNII:3I798OGQ8B

object_name: Anatomic Stage III Breast Cancer AJCC v8


subject: CHEBI:91951


subject: CHEBI:91951


subject: CHEBI:91951


subject: PUBCHEM.COMPOUND:17756771

subject_name: Fulvestrant


subject: PUBCHEM.COMPOUND:17756771


subject: PUBCHEM.COMPOUND:17756771


subject: UMLS:C1518041

subject_name: Luteinizing Hormone-releasing Hormone Agonist


subject: UMLS:C1518041


subject: UMLS:C1518041


subject: UMLS:C1518041


subject: UMLS:C1518041


subject: UMLS:C1518041


subject: CHEBI:6413

subject_name: Letrozole


subject: CHEBI:6413


subject: CHEBI:6413


subject: CHEBI:6413


subject: CHEBI:41774

subject_name: Tamoxifen


subject: CHEBI:41774


subject: CHEBI:41774


subject: CHEBI:41774


subject: UMLS:C4721525

subject_name: Therapeutic Estradiol


subject: UMLS:C4721525


subject: UMLS:C4721525


subject: UMLS:C4721525


subject: CHEBI:23965

subject_name: estradiol


subject: CHEBI:23965


subject: CHEBI:3077

subject_name: Betamethasone

object_name: Addison Disease


subject: CHEBI:7820

subject_name: Oxandrolone

object_name: spinal cord injury


subject: UNII:RM16A4BA8R

subject_name: OBEXELIMAB

object_name: Immunoglobulin G4-Related Disease


subject: CHEBI:3614

subject_name: Chlorhexidine

object_name: Neonatal infection


subject: CHEBI:2376

subject_name: acarbose

object_name: Overweight or obesity


subject: CHEBI:28976

subject_name: carbonic acid

object_name: metabolic acidosis


subject: UMLS:C2722820

subject_name: Bicarbonate preparation


subject: MESH:D001639

subject_name: Bicarbonates


subject: CHEBI:17544

subject_name: Bicarbonate Ion


subject: CHEBI:16347

subject_name: Levocarnitine

object_name: Treatment Resistant Disorders


subject: UMLS:C2987633

subject_name: Multikinase Inhibitor AT9283

object_name: unspecified childhood solid tumor, protocol specific


subject: UMLS:C0935906

subject_name: Monoclonal Antibody Mono-dgA-RFB4

object_name: adult lymphoma


subject: UMLS:C0935906

object_name: lymphoma


subject: UMLS:C0935906

object_name: pediatric lymphoma


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside

object_name: esophageal adenocarcinoma


subject: PUBCHEM.COMPOUND:131769963

object_name: lung adenocarcinoma


subject: PUBCHEM.COMPOUND:131769963

object_name: cervical adenocarcinoma


subject: PUBCHEM.COMPOUND:131769963

object_name: adenocarcinoma


subject: PUBCHEM.COMPOUND:131769963

object_name: bile duct adenocarcinoma


subject: PUBCHEM.COMPOUND:131769963

object_name: gastric adenocarcinoma


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEMBL.COMPOUND:CHEMBL2108553

subject_name: PEPPERMINT

object_name: Childhood Breast Carcinoma


subject: CHEMBL.COMPOUND:CHEMBL2108553

object_name: breast carcinoma


subject: CHEMBL.COMPOUND:CHEMBL2108553

object_name: breast cancer


subject: CHEMBL.COMPOUND:CHEMBL2108553

object_name: female reproductive organ cancer


subject: UMLS:C0070324

subject_name: peppermint preparation


subject: UMLS:C0070324


subject: UMLS:C0070324


subject: UMLS:C0070324


subject: UMLS:C1618310

subject_name: stinging nettle extract


subject: UMLS:C1618310


subject: UMLS:C1618310


subject: UMLS:C1618310